Bionano Genomics (LTS:0A4K) Other Long-Term Liabilities : $-0.00 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Bionano Genomics Other Long-Term Liabilities?

Bionano Genomics's other long-term liabilities for the quarter that ended in Mar. 2025 was $-0.00 Mil.

Bionano Genomics's quarterly other long-term liabilities increased from Sep. 2024 ($-0.00 Mil) to Dec. 2024 ($0.00 Mil) but then declined from Dec. 2024 ($0.00 Mil) to Mar. 2025 ($-0.00 Mil).

Bionano Genomics's annual other long-term liabilities declined from Dec. 2022 ($12.97 Mil) to Dec. 2023 ($10.89 Mil) and declined from Dec. 2023 ($10.89 Mil) to Dec. 2024 ($0.00 Mil).

Bionano Genomics Other Long-Term Liabilities Historical Data

The historical data trend for Bionano Genomics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionano Genomics Other Long-Term Liabilities Chart

Bionano Genomics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

9.07

12.97

10.89

Bionano Genomics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial															10.25	5.77	-	-	-

Bionano Genomics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Bionano Genomics Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Bionano Genomics's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionano Genomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionano Genomics Inc (LTS:0A4K) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

BNGO:USA BNGO:Mexico

Address

9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121

Website

https://www.bionano.com

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Bionano Genomics Headlines

No Headlines